Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Litigation Settlements topic
No spam. Unsubscribe anytime.
Altus council unanimously adopts resolution to join Purdue bankruptcy settlements and manufacturer agreements
Summary
The Altus City Council adopted Resolution 2025-18 authorizing the city to participate in the thirteenth amended chapter 11 plan for Purdue Pharma L.P., a governmental-entity settlement agreement dated June 17, 2025, and related manufacturer settlement agreements; the council authorized the mayor or the mayor’s designee to execute participation and
The Altus City Council on June 17, 2025, adopted Resolution 2025-18 approving the city’s participation in the thirteenth amended chapter 11 plan of reorganization for Purdue Pharma L.P., authorizing voting to accept a governmental-entity settlement agreement dated June 17, 2025 (GESA), and approving participation in a series of manufacturer settlement agreements.
The resolution authorizes council legal counsel to vote by master ballot or otherwise to accept the Purdue plan, approves the city’s participation in the GESA, and authorizes the mayor or the mayor’s designee to execute subdivision participation forms required by the plan and the GESA. It also approves participation in settlement agreements with multiple manufacturers and authorizes the mayor or designee to sign combined subdivision participation forms related to those manufacturer settlements.
Under the resolution the council authorized participation in settlements with, among others, Alvogen Inc.; Amneal Pharmaceuticals, Inc.; Apotex Inc.; Hikma Pharmaceuticals USA Inc.; Indivior Inc.; Mylan Pharmaceuticals Inc.; Sandoz Inc.; Sun Pharmaceutical Industries Ltd.; and Zydus Pharmaceuticals. The resolution instructs city legal counsel to vote to accept the plan and related agreements as needed by the claims-resolution process in the Purdue bankruptcy proceedings.
Why this matters: the settlements and the chapter 11 plan are part of nationwide litigation and bankruptcy proceedings tied to opioid claims; participation determines what claims, releases, or recovery the city may accept or pursue as the broader national settlement process moves forward.
The council’s vote was recorded as unanimous. The roll-call sequence in the transcript shows affirmations by Councilmember Jonathan Bergmark; Councilmember Joel Jinx; Councilmember Reister; Councilmember Malcolm Dash; Councilmember Austin Leverett; Councilmember Roberta Brady (recorded in the meeting as “Brady Lee”); Councilmember Sally Maines; Councilmember Cody Nelson; and Councilmember Robert Garrison.
The council had met in an executive session immediately before the vote to hold confidential communications with counsel about the proposed settlements and related litigation, including matters tied to the Purdue bankruptcy and other pharmaceutical-related lawsuits. The meeting record shows the city discussed the pending federal cases in closed session under the authority cited in state law during that executive-session discussion.
No financial figures for the city’s expected recovery or allocation were specified in the discussion recorded in the transcript. The resolution text and the related participation forms were described at the meeting; the mayor or the mayor’s designee is authorized to sign documents required to enroll the city in these settlement processes.
The council moved on to other agenda items after adopting Resolution 2025-18.
